Clinical Trials on Anticoagulant Antagonist Toxicity in Belgium

Total 32 results

Universitaire Ziekenhuizen KU Leuven
Bristol-Myers Squibb

Completed

Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

ESRD | Anticoagulant Toxicity

Belgium
University Hospital, Ghent

Active, not recruiting

Dialysis Performance of the FX CorAL Membrane (PATENCY)

Hemodialysis Complication | Anticoagulants

Belgium
Prothya Biosolutions

Completed

Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

CPB | Oral Anticoagulant Therapy

Belgium
Jessa Hospital
Hasselt University

Completed

Novel Skin Care for Chemotherapy- Related Dermatologic Toxicities (ChemoSkin)

Skin Toxicity

Belgium
Jessa Hospital
Hasselt University

Recruiting

Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities (ImmunoSkin)

Immunotoxicity | Skin Toxicity

Belgium
University Hospital, Ghent

Completed

Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting (ClotVar)

Hemodialysis Complication | Anticoagulants

Belgium
KU Leuven

Completed

Effect of Increased Protein Intake on Colonic Metabolism

Protein Fermentation | Toxicity in the Colon

Belgium
Hasselt University
Jessa Hospital

Unknown

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

Incidence of Readmissions | ADE's Due to Anticoagulants

Belgium
Universitair Ziekenhuis Brussel
University Ghent; Vrije Universiteit Brussel

Not yet recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. (PABTOX)

Breast Cancer | Body Weight | Chemotherapeutic Toxicity | Physical Inactivity | Chemotherapeutic Agent Toxicity | Paclitaxel Adverse Reaction

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (ARNEO)

Prostate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen Antagonists

Belgium
Erasme University Hospital

Completed

Anticoagulation and Antiplatelet Management During Perioperative Period (OMAHA)

Anticoagulants and Bleeding Disorders

Belgium
CRG UZ Brussel
KU Leuven; Abbott; Universitätsklinikum Hamburg-Eppendorf

Completed

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Infertility | Infertility, Female | Dydrogesterone | Genital Diseases, Female | Progesterone | Hormones | Physiological Effects of Drugs | Genital Diseases, Male | Hormones, Hormone Substitutes, and Hormone Antagonists | Progestins

Belgium
University Hospital, Ghent
Kom Op Tegen Kanker

Completed

Pre- or Postoperative Accelerated Radiotherapy (POP-ART)

Breast Cancer | Radiation Toxicity

Belgium
University Hospital, Ghent

Completed

External Beam Radiotherapy for Muscle Invasive Bladder Cancer

Toxicity

Belgium
R&D Cardiologie

Completed

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) (WOEST)

Atrial Fibrillation | Stents | Anticoagulants | Platelet Aggregation Inhibitors

Netherlands, Belgium
Universitair Ziekenhuis Brussel

Unknown

Exercise Response After Revalidation in Cancer Patients

Oncology | Cardiac Toxicity

Belgium
Jessa Hospital

Withdrawn

A Novel Skin Barrier Protectant for Acute Radiodermatitis (CASP-ORL)

Skin Diseases | Head and Neck Cancer | Radiation Toxicity | Radiodermatitis | Radiation Dermatitis

Belgium
University Hospital, Ghent

Active, not recruiting

Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer

Toxicity

Belgium
University Hospital, Antwerp
CytoSorbents Europe GmbH

Not yet recruiting

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device (COOLEY)

Acute-On-Chronic Liver Failure | Sarcopenia | Ultrasonography | Anticoagulant Adverse Reaction

Belgium
Centre Hospitalier Universitaire Saint Pierre

Recruiting

Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia

Spinal Anesthesia | Cardiac Toxicity

Belgium
Centre Hospitalier Universitaire Saint Pierre
Masimo Corporation; Centre Hospitalier Universitaire Brugmann

Completed

ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest (ORI-ONE)

Out-Of-Hospital Cardiac Arrest | Oxygen Toxicity

Belgium
Jessa Hospital
Hasselt University

Completed

An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic (COVID-ONCO)

Covid19 | PROMs | Chemotherapeutic Toxicity | Oncology

Belgium
European Organisation for Research and Treatment...

Terminated

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

Spain, France, Belgium, Italy, United Kingdom, Turkey
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
Jessa Hospital

Completed

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) (Prophylaxis001)

Bladder Cancer | Antibiotic-associated Diarrhea | Antibiotic Resistant Infection | Antibiotic Resistant Strain | Antibiotic Toxicity | Prostate Hyperplasia | Urosepsis

Belgium
CeloNova BioSciences, Inc.

Unknown

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE)

Angina, Stable | Angina, Unstable | Anticoagulants

United States, Denmark, France, Germany, Belgium, Italy, Latvia, Switzerland
Drahomir Aujesky
Bayer; The Ottawa Hospital; University of Bern; Leiden University Medical Center; Schweizerischer Nationalfonds

Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism (SAFE-SSPE)

Cardiovascular Diseases | Respiratory Tract Diseases | Lung Diseases | Embolism | Embolism and Thrombosis | Bleeding | Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

Netherlands, Switzerland, Belgium, France, Canada
Byondis B.V.

Completed

Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985

Metastatic Breast Cancer

France, Belgium, Spain
Sabine Rhode
Ruhr University of Bochum

Unknown

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (PIPACRegis)

Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural Cancer

Singapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
ImmunoGen, Inc.

Not yet recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer | Folate Receptor-Alpha Positive

United States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3)

Urogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditions

China, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
UMC Utrecht
M.D. Anderson Cancer Center; Odense University Hospital; Radboud University Medical... and other collaborators

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (MOMENTUM)

Neoplasms | Quality of Life | Breast Cancer | Head and Neck Cancer | Head and Neck Neoplasms | Gynecologic Cancer | Liver Neoplasms | Pancreatic Neoplasms | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Rectal Neoplasms | Prostate Cancer | Brain Cancer | Brain Tumor | Bladder Cancer | Liver Metastases | T... and other conditions

United States, Netherlands, Germany, Canada, Denmark, United Kingdom, Australia, Belgium, Italy

Clinical Trials on Anticoagulant Antagonist Toxicity in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations